The Feed Additive Nosiheptide Premix Market size was valued at USD 728.9 million in 2024 and is anticipated to reach USD 1,452.38 million by 2032, at a CAGR of 9% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Feed Additive Nosiheptide Premix Market Size 2024
USD 728.9 million
Feed Additive Nosiheptide Premix Market, CAGR
9%
Feed Additive Nosiheptide Premix Market Size 2032
USD 1,452.38 million
Top players in the feed additive nosiheptide premix market include Zhejiang University Sunny Nutrition Technology, ZHEJIANG ESIGMA BIOTECHNOLOGY CO., LTD., FENGCHEN GROUP CO., LTD., Zhejiang Esigma Animal Health, and Chattha Group. These companies lead through high-quality production, regional distribution strength, and compliance with veterinary standards. Asia-Pacific dominates the market with a 60% share in 2024, driven by large-scale poultry and livestock operations in China and India. Local manufacturing, favorable regulations, and demand for performance-enhancing feed solutions support the region’s leadership. Key players focus on supply chain partnerships with feed mills and integrated farms to strengthen long-term growth.
Feed Additive Nosiheptide Premix Market Insights
The Feed Additive Nosiheptide Premix Market was valued at USD 728.9 million in 2024 and is projected to reach USD 1,452.38 million by 2032, growing at a CAGR of 9% during the forecast period.
Growth is driven by rising demand for antimicrobial growth promoters in commercial livestock and poultry farming, especially to improve feed efficiency and disease control.
A key trend is the shift toward precision nutrition, with feed manufacturers offering customized nosiheptide concentrations for different species and growth stages.
Asia-Pacific holds the largest regional share at 60%, followed by North America at 15%; the poultry application segment leads with over 70% share, while “Between 4 to 12 percent” concentration dominates with 65% share.
Regulatory restrictions in Europe and increasing preference for natural feed additives such as probiotics and essential oils present key challenges for nosiheptide premix adoption across regulated and premium markets.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
The “Between 4 to 12 percent” concentration segment holds the dominant share in the nosiheptide premix market, accounting for over 65% of total sales in 2024. This concentration range is widely preferred due to its higher efficacy in controlling bacterial infections and promoting animal growth. Feed producers favor it for its balance of potency and cost-efficiency in large-scale operations. Its adoption across commercial farms supports consistent feed formulations. Additionally, flexible dosage allows precise tailoring for different livestock types, enhancing performance while meeting regulatory residue limits across global markets.
For instance, Nosiheptide premix inclusion at a rate of 2 to 5 mg per kilogram of feed effectively suppresses Clostridium perfringens in controlled poultry trials.
By Application
The poultry segment leads the application category with more than 70% share of the nosiheptide premix market in 2024. High demand stems from the poultry industry’s need for growth promotants and feed efficiency enhancers. Broiler and layer producers rely on nosiheptide to manage Clostridium and necrotic enteritis, which impact feed conversion ratios and mortality. The compound’s stability in pelleted feed and proven efficacy at low inclusion levels support its broad usage. Rising poultry meat consumption and shorter production cycles further drive repeat demand across integrated operations.
For instance, Elanco feed studies document improved feed conversion ratios when nosiheptide is applied at 20 mg per ton in broiler diets.
By Distribution Channel
Feed manufacturers represent the dominant distribution channel, contributing nearly 60% of market revenue in 2024. These manufacturers incorporate nosiheptide premix directly into compound feed formulations, streamlining supply and dosage control. Their strong purchasing power enables bulk procurement, supporting cost savings and stable sourcing. Long-term supplier agreements and integration with feed production systems make this channel the preferred route for consistent demand. In contrast, veterinary pharmacies and online distributors cater to smallholders and niche farms requiring flexibility and lower-volume purchases.
Rising Demand for Antimicrobial Growth Promoters in Poultry and Livestock Feed
The increasing need for efficient feed additives that enhance animal health and growth performance is a major driver in the nosiheptide premix market. Producers in poultry and livestock sectors seek alternatives to traditional antibiotics, especially with rising global meat consumption. Nosiheptide, a polypeptide antibiotic, supports gut health and reduces pathogen load, leading to better weight gain and feed efficiency. It also reduces mortality caused by enteric diseases like necrotic enteritis in broilers and bacterial infections in swine. Unlike some antibiotic growth promoters (AGPs), nosiheptide shows low resistance development, which supports its continued use under evolving regulatory scrutiny. Countries in Asia-Pacific, especially China and India, show strong demand due to intensive poultry farming and rapid industrialization of animal husbandry. With increasing pressure on producers to boost yields without compromising food safety, the adoption of safe and efficient additives like nosiheptide remains a strategic necessity.
For instance, Elanco Animal Health trials showed nosiheptide inclusion at 20 milligrams per ton of feed reduced Clostridium perfringens counts by more than 2 log units in broiler intestines.
Expansion of Commercial Animal Farming and Compound Feed Production
The growth of intensive animal farming and modern feed mills strongly contributes to the uptake of nosiheptide premix. As livestock and poultry farms transition from traditional to commercial operations, there is a shift toward standardized feeding practices. Compound feed manufacturers prefer additives like nosiheptide for their proven efficacy, stability in formulation, and ease of blending. Rising meat and egg consumption, especially in emerging markets, drives the expansion of integrated supply chains and boosts demand for performance-enhancing additives. Additionally, the vertical integration of farming operations enables streamlined procurement and consistent additive usage across large-scale feed plants. In developed markets, increasing automation and precision feeding technologies further reinforce the use of standardized additives such as nosiheptide. As feed production grows to support rising animal populations, demand for consistent and regulated premix solutions rises in tandem.
For instance, New Hope Liuhe operates an extensive network of over 240 feed mills with a total annual sales volume exceeding 28 million metric tons as of 2024. While the company historically utilized additives like nosiheptide to enhance growth and feed efficiency, its current 2025 strategy focuses on digital nutrition systems and intelligent farming to ensure uniform poultry diets while adhering to modern antibiotic-reduction standards.
Favorable Regulatory Framework in Key Producing Countries
In several Asian and Latin American markets, regulatory frameworks remain supportive of using antibiotic premixes like nosiheptide, especially for non-therapeutic growth promotion. While many Western countries have tightened rules on AGPs, other regions continue to approve nosiheptide under controlled conditions. For instance, China’s Ministry of Agriculture has authorized nosiheptide for poultry and swine feed, with maximum residue limits (MRLs) and safe withdrawal periods. Such frameworks provide clear guidelines for manufacturers and ensure continued market access. Regulatory stability also encourages local production and investment in feed additive facilities. As governments seek to balance animal productivity and food safety, nosiheptide offers a reliable option with a well-established safety profile. Ongoing support for veterinary premix use in several markets ensures a strong base for growth, even as alternatives like probiotics and enzymes emerge in parallel.
Shift Toward Precision Nutrition and Customized Feed Additives
One major trend shaping the nosiheptide premix market is the shift toward precision nutrition in animal husbandry. Large commercial farms and integrators now focus on optimizing feed conversion ratios (FCR) and tailoring feed compositions to specific growth stages or animal health conditions. This approach drives demand for more targeted additive use, including adjusted nosiheptide concentrations based on production needs. Manufacturers offer premixes in customized strengths or combined formulations to match specific poultry or swine operations. Digital tools and feed management software further enhance precision in additive dosing. This customization helps farms reduce overuse, comply with guidelines, and maximize efficiency. As precision feeding becomes standard in developed markets and gains ground in emerging regions, additive suppliers that offer flexible nosiheptide premix solutions will likely benefit from expanded product uptake.
For instance, Cargill’s digital feed management platforms ensure highly precise micro-ingredient dosing across automated feed lines. DSM Animal Nutrition (now dsm-firmenich) trials confirm that precision-fed broilers, when their nutrition is adjusted by age phase, consistently achieve excellent feed conversion ratios (FCR), often well below the industry standard of 1.6.
Growing Adoption in Emerging Economies with Expanding Meat Production
Emerging economies offer strong growth opportunities for nosiheptide premix suppliers due to expanding livestock and poultry production. Countries such as Brazil, India, Indonesia, and Vietnam are scaling up meat and egg output to meet rising domestic demand. In these regions, feed manufacturers and animal producers seek affordable, reliable additives to improve growth rates and feed utilization. Nosiheptide, with its proven record in broiler and swine health, fits this demand profile. Its shelf-stable nature and compatibility with existing feed processing systems make it easy to deploy at scale. Additionally, government programs to modernize agriculture and enhance food security indirectly support the uptake of such feed additives. Local production of nosiheptide premix is also increasing to reduce import dependency and support domestic availability. As infrastructure and veterinary awareness improve in these markets, the adoption of scientifically validated additives like nosiheptide is expected to grow further.
A significant challenge for the nosiheptide premix market lies in increasingly stringent regulations in North America and Europe. Several countries in these regions have either banned or tightly controlled the use of antibiotic growth promoters in animal feed due to concerns over antimicrobial resistance (AMR). Although nosiheptide shows low cross-resistance, its classification as an antibiotic makes it subject to cautious scrutiny. Regulatory shifts can lead to declining adoption, loss of market access, or higher compliance costs for producers. Import restrictions and labeling rules also complicate international trade in premixed feed containing such additives. With increasing global collaboration on AMR monitoring, even permissive markets may tighten regulations. As a result, suppliers face the dual burden of maintaining safety standards and diversifying into non-antibiotic alternatives to mitigate regulatory risks.
Rise of Alternative Additives and Natural Feed Solutions
Competition from natural and non-antibiotic feed additives poses a growing threat to the nosiheptide premix market. Products such as probiotics, prebiotics, essential oils, and organic acids are gaining favor as safer, consumer-friendly alternatives. These solutions claim to support gut health, immunity, and growth without contributing to antimicrobial resistance. Regulatory backing and consumer pressure for antibiotic-free meat further drive their adoption. Multinational feed companies invest heavily in research and marketing of these alternatives, which can erode the demand for antibiotic premixes. In premium segments or export-oriented farms, the shift away from AGPs is particularly strong. For nosiheptide producers, this trend requires strategic repositioning, greater transparency, and potential portfolio diversification to remain competitive in evolving feed additive landscapes.
Asia-Pacific dominates the feed additive nosiheptide premix market with a market share of over 60% in 2024, driven by intensive livestock and poultry farming in China, India, and Southeast Asia. High meat consumption, rapid urbanization, and the presence of large-scale feed manufacturers fuel regional demand. China remains the largest consumer due to its high broiler production and government-supported feed modernization programs. India’s growing poultry sector and affordable feed additive adoption further boost market presence. Favorable regulatory frameworks and local production capabilities support cost-effective supply and accessibility across rural and commercial farming zones, strengthening regional leadership.
North America
North America holds approximately 15% of the global nosiheptide premix market in 2024, with moderate growth driven by the poultry segment. While regulatory scrutiny on antibiotic use in animal feed limits broader adoption, targeted use in therapeutic and controlled growth applications continues. The U.S. sees steady demand in broiler and turkey production, especially under veterinary oversight. Feed manufacturers emphasize compliance and transparency, favoring certified additives. Market players explore reformulated products to align with evolving FDA guidelines. Despite a shift toward antibiotic alternatives, selective use of nosiheptide persists in high-efficiency commercial operations seeking performance enhancement.
Europe
Europe accounts for nearly 10% of the global nosiheptide premix market in 2024, constrained by stringent antibiotic regulations and consumer pushback against AGPs. The European Union’s ban on antibiotic growth promoters has redirected focus toward non-antibiotic alternatives, reducing nosiheptide adoption. However, limited usage persists under veterinary prescription in specific health interventions. Demand centers in Eastern European countries where enforcement is less restrictive, and poultry and swine operations still use permitted additives. Stringent residue limits and labeling norms continue to shape supplier strategies. The region remains a challenge for sustained growth, with pressure to invest in alternative product development.
Latin America
Latin America holds a 9% share of the nosiheptide premix market in 2024, supported by the growth of commercial livestock farming across Brazil, Mexico, and Argentina. Expanding meat exports and demand for feed performance solutions drive additive use in compound feed. Brazil leads regional consumption due to its dominant poultry production sector and flexible additive regulations. Nosiheptide is favored for its cost-efficiency and role in improving feed conversion ratios. Veterinary channels and integrated farming systems support direct additive distribution. Rising investments in feed manufacturing and animal health technologies are expected to sustain growth across this developing region.
Middle East & Africa
The Middle East & Africa represent around 6% of the global nosiheptide premix market in 2024, with demand growing in poultry and dairy feed applications. Countries like South Africa, Egypt, and Saudi Arabia see rising meat consumption and gradual industrialization of animal farming. Feed manufacturers adopt nosiheptide to reduce disease incidence and improve production margins. Regulatory oversight varies, enabling moderate use in commercial formulations. Imports continue to dominate supply, though local blending facilities are expanding. As veterinary infrastructure and feed quality standards improve, the region offers long-term potential despite short-term constraints like fragmented distribution and price sensitivity.
The competitive landscape of the feed additive nosiheptide premix market is moderately consolidated, with a mix of regional and international players competing on product quality, regulatory compliance, and supply reliability. Leading manufacturers such as Zhejiang University Sunny Nutrition Technology, ZHEJIANG ESIGMA BIOTECHNOLOGY CO., LTD., and FENGCHEN GROUP CO., LTD. maintain strong positions through integrated production, established distribution networks, and adherence to veterinary safety standards. Companies focus on offering high-purity formulations, consistent potency, and compatibility with compound feed systems. Strategic partnerships with feed mills and livestock integrators enhance long-term supply contracts. Emerging players, including Chattha Group, target cost-sensitive markets with competitive pricing and expanding export footprints. Continuous investment in production efficiency and quality control remains critical to differentiation, especially under tightening residue and labeling regulations. With growing pressure to balance performance with sustainability, market participants increasingly explore product innovation and possible diversification into non-antibiotic or multi-functional premix solutions to retain market share.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In 2025, FENGCHEN participated in the China Chengdu International Pharmaceutical Exhibition, highlighting its veterinary premix offerings amid a challenging export environment for APIs. The company made a prominent appearance at CPHI & PMEC China, showcasing its pharmaceutical and veterinary API/premix products, which include feed additives.
In 2025, the company’s Nosiheptide Premix product for use in layer hens with a zero-day egg withdrawal period. This expands its application beyond traditional swine and broiler uses, enhancing its market potential for poultry egg production. The approval highlights Nosiheptide’s low residue profile and efficacy against gram-positive bacteria like Clostridium perfringens.
Report Coverage
The research report offers an in-depth analysis based on Concentration, Application,Distribution Channeland Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
Demand will remain strong in poultry and livestock feed due to efficiency gains.
Asia-Pacific will continue to lead consumption with expanding commercial farming.
Feed manufacturers will increase direct integration of nosiheptide premix.
Customized concentration formats will gain wider adoption across species.
Precision nutrition practices will support controlled and optimized usage.
Emerging markets will drive volume growth through feed industry expansion.
Regulatory pressure will encourage stricter compliance and traceability systems.
Competition will intensify around quality, consistency, and supply reliability.
Producers will explore blended premix solutions to improve value.
Long-term growth will depend on balancing performance benefits with sustainability expectations.
1. Introduction
1.1. Report Description
1.2. Purpose of the Report
1.3. USP & Key Offerings
1.4. Key Benefits for Stakeholders
1.5. Target Audience
1.6. Report Scope
1.7. Regional Scope
2. Scope and Methodology
2.1. Objectives of the Study
2.2. Stakeholders
2.3. Data Sources
2.3.1. Primary Sources
2.3.2. Secondary Sources
2.4. Market Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
2.5. Forecasting Methodology
3. Executive Summary
4. Introduction
4.1. Overview
4.2. Key Industry Trends
5. Global Feed Additive Nosiheptide Premix Market
5.1. Market Overview
5.2. Market Performance
5.3. Impact of COVID-19
5.4. Market Forecast
9. Market Breakup by Region
9.1. North America
9.1.1. United States
9.1.1.1. Market Trends
9.1.1.2. Market Forecast
9.1.2. Canada
9.1.2.1. Market Trends
9.1.2.2. Market Forecast
9.2. Asia-Pacific
9.2.1. China
9.2.2. Japan
9.2.3. India
9.2.4. South Korea
9.2.5. Australia
9.2.6. Indonesia
9.2.7. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. United Kingdom
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Others
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Others
9.5. Middle East and Africa
9.5.1. Market Trends
9.5.2. Market Breakup by Country
9.5.3. Market Forecast
12. Porter’s Five Forces Analysis
12.1. Overview
12.2. Bargaining Power of Buyers
12.3. Bargaining Power of Suppliers
12.4. Degree of Competition
12.5. Threat of New Entrants
12.6. Threat of Substitutes
13. Price Analysis
14. Competitive Landscape
14.1. Market Structure
14.2. Key Players
14.3. Profiles of Key Players
14.3.1. Zhejiang University Sunny Nutrition Technology
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. Financials
14.3.1.4. SWOT Analysis
14.3.2. ZHEJIANG ESIGMA BIOTECHNOLOGY CO., LTD.
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. Financials
14.3.2.4. SWOT Analysis
14.3.3. FENGCHEN GROUP CO., LTD.
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. Financials
14.3.3.4. SWOT Analysis
14.3.4. Chattha Group
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. Financials
14.3.4.4. SWOT Analysis
14.3.5. Zhejiang Esigma Animal Health
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. Financials
14.3.5.4. SWOT Analysis
14.3.6. Others
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. Financials
14.3.6.4. SWOT Analysis
15. Research Methodology
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the current market size for Feed Additive Nosiheptide Premix Market, and what is its projected size in 2032?
The market size was USD 728.9 million in 2024 and is projected to reach USD 1,452.38 million by 2032.
At what Compound Annual Growth Rate is the Feed Additive Nosiheptide Premix Market projected to grow between 2024 and 2032?
The market is projected to grow at a CAGR of 9% during the forecast period.
Which Feed Additive Nosiheptide Premix Market segment held the largest share in 2024?
The “Between 4 to 12 percent” concentration and poultry application segment held the largest shares in 2024.
What are the primary factors fueling the growth of the Feed Additive Nosiheptide Premix Market?
Key drivers include rising demand for antimicrobial growth promoters and the expansion of commercial animal farming.
Who are the leading companies in the Feed Additive Nosiheptide Premix Market?
Leading companies include Zhejiang University Sunny Nutrition Technology, ESIGMA, FENGCHEN GROUP, and Chattha Group.
Which region commanded the largest share of the Feed Additive Nosiheptide Premix Market in 2024?
Asia-Pacific held the largest share at 60% in 2024, led by China and India.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The Agriculture in Israel Market is projected to grow from USD 13,102.37 million in 2025 to an estimated USD 16,726.33 million by 2032, with a compound annual growth rate (CAGR) of 3.6% from 2025 to 2032.
The Agricultural Pyrethroids Market is projected to grow from USD 15,327.78 million in 2025 to an estimated USD 22,744.63 million by 2032, with a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032.
The Agricultural Colorants Market is projected to grow from USD 2,206.49 million in 2025 to an estimated USD 3,252.57 million by 2032, with a compound annual growth rate (CAGR) of 5.70% from 2025 to 2032.
The Agricultural Biologicals Testing Market is projected to grow from USD 2,487.5 million in 2025 to an estimated USD 5,262.95 million by 2032, with a compound annual growth rate (CAGR) of 11.3% from 2025 to 2032.
The Agricultural and Farm Machinery Market is projected to grow from USD 178,315.4 million in 2025 to an estimated USD 231,510.3 million by 2032, with a compound annual growth rate (CAGR) of 3.8% from 2025 to 2032.
The global Bromadiolone Market size was estimated at USD 500.3 million in 2025 and is expected to reach USD 729.23 million by 2032, growing at a CAGR of 5.53% from 2025 to 2032.
The global Biopesticides Market size was estimated at USD 8952.2 million in 2025 and is expected to reach USD 22956.83 million by 2032, growing at a CAGR of 14.4% from 2025 to 2032.
The global Biorational Pesticides Market size was estimated at USD 7,712.2 million in 2025 and is expected to reach USD 17,698.93 million by 2032, growing at a CAGR of 12.6% from 2025 to 2032.
The global Bioinsecticides Market size was estimated at USD 140.43 million in 2025 and is expected to reach USD 287.89 million by 2032, growing at a CAGR of 10.8% from 2025 to 2032.
The Agricultural Robots and Mechatronics Market is projected to grow from USD 4300.22 million in 2025 to an estimated USD 11971.2 million by 2032, with a compound annual growth rate (CAGR) of 15.8% from 2025 to 2032.
The Agricultural Coatings Market is projected to grow from USD 2,966.05 million in 2025 to an estimated USD 4,145.79 million by 2032, with a compound annual growth rate (CAGR) of 4.90% from 2025 to 2032.
The Animal Nutrition Market size was valued at USD 45,668.60 million in 2024 and is anticipated to reach USD 71,697.34 million by 2032, at a CAGR of 5.8% during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
